|
|
|
|
CHROMABOND® Drug
|
|
| special silica phase for SPE enrichment of drugs from urine or plasma |
|
|
|
| Features |
|
|
base material silica, pore size 60 Å, particle size 45 µm, specific surface 500 m2/g, pH stability 2 – 8
special bifunctional modification - C8 / SA (strong cation exchanger - benzenesulphonic acid)
|
|
recommended application:
enrichment of acidic, neutral and basic drugs from urine or plasma (e.g. application 302020)
|
Ordering information
|
|
Volume
|
Adsorbent weight
|
Pack of |
|
|
CHROMABOND® Drug polypropylene columns
|
|
|
100 mg |
200 mg
|
500 mg
|
|
|
|
1 ml
|
730681
|
|
|
|
100 |
|
3 ml
|
|
730168 |
730684
|
|
50 |
|
6 ml
|
|
|
730682
|
|
30 |
|
CHROMABOND® Drug polypropylene columns · BIGpack
|
|
|
|
|
200 mg
|
|
|
|
|
|
1 ml
|
|
730168.250
|
|
|
250 |
|
|
CHROMABOND® LV-Drug
|
|
|
|
200 mg
|
|
|
|
|
15 ml
|
|
732168
|
|
|
30 |
|
|
CHROMABOND® MULTI 96 Drug
|
|
|
|
|
|
96 x 100 mg
|
|
|
|
|
|
|
738161.100M
|
1
|
|
|
|
|
|
|
|
|
|
  |
|
|
 |